Capital Research Global Investors
Position in GILD — Gilead Sciences, Inc.
CIK 1422848
Los Angeles, CA
Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,780,764,274
+$674,574,380 QoQ
Shares Held
27,127,533
+7.2% QoQ
Ownership
2.18%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.95892733777156.ToString("F0")%
Shared 0.ToString("F0")%
None 0.041072662228445175.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $39,059,483,079 across 9 Drug Manufacturers - General names. GILD ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,632,647 | $22,656,369,731 | |
| 2 | ABBV |
AbbVie Inc.
|
31,254,786 | $6,797,603,407 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
27,127,533 | $3,780,764,274 | |
| 4 | AMGN |
Amgen Inc
|
6,955,345 | $2,447,238,138 | |
| 5 | JNJ |
Johnson & Johnson
|
8,739,988 | $2,136,402,666 | |
| 6 | AZN |
Astrazeneca PLC
|
4,611,176 | $909,416,130 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,061,571 | $247,986,375 | |
| 8 | SNY |
Sanofi
|
1,661,837 | $80,067,306 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,780,764,274 | 27,127,533 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,106,189,894 | 25,307,071 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,331,559,106 | 30,014,046 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,447,799,670 | 31,097,679 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,119,091,958 | 54,610,370 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,352,493,080 | 57,946,228 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,181,284,416 | 61,799,671 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,145,945,457 | 60,427,714 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,486,296,309 | 61,246,366 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,832,823,777 | 59,657,126 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,340,053,277 | 57,913,708 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,462,327,489 | 57,899,669 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,835,334,537 | 58,278,107 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,687,663,429 | 54,602,952 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,323,577,744 | 53,875,470 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,459,875,323 | 55,975,980 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,326,309,481 | 55,951,379 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $7,780,668,390 | 107,156,981 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,001,185,343 | 114,548,108 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,034,003,277 | 116,671,555 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,924,047,624 | 122,606,338 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $7,088,633,965 | 121,672,399 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,400,386,077 | 117,113,247 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,644,958,501 | 125,356,882 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,175,638,168 | 95,982,319 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||